1. Home
  2. ATRC vs XHR Comparison

ATRC vs XHR Comparison

Compare ATRC & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • XHR
  • Stock Information
  • Founded
  • ATRC 2000
  • XHR 2007
  • Country
  • ATRC United States
  • XHR United States
  • Employees
  • ATRC N/A
  • XHR N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • XHR Real Estate Investment Trusts
  • Sector
  • ATRC Health Care
  • XHR Real Estate
  • Exchange
  • ATRC Nasdaq
  • XHR Nasdaq
  • Market Cap
  • ATRC 1.6B
  • XHR 1.5B
  • IPO Year
  • ATRC 2005
  • XHR N/A
  • Fundamental
  • Price
  • ATRC $31.76
  • XHR $13.20
  • Analyst Decision
  • ATRC Strong Buy
  • XHR Hold
  • Analyst Count
  • ATRC 10
  • XHR 6
  • Target Price
  • ATRC $49.60
  • XHR $13.58
  • AVG Volume (30 Days)
  • ATRC 424.4K
  • XHR 981.6K
  • Earning Date
  • ATRC 07-29-2025
  • XHR 08-01-2025
  • Dividend Yield
  • ATRC N/A
  • XHR 4.25%
  • EPS Growth
  • ATRC N/A
  • XHR 16.62
  • EPS
  • ATRC N/A
  • XHR 0.22
  • Revenue
  • ATRC $480,076,000.00
  • XHR $1,060,486,000.00
  • Revenue This Year
  • ATRC $14.63
  • XHR $3.27
  • Revenue Next Year
  • ATRC $12.62
  • XHR $3.26
  • P/E Ratio
  • ATRC N/A
  • XHR $60.16
  • Revenue Growth
  • ATRC 15.79
  • XHR 3.57
  • 52 Week Low
  • ATRC $20.20
  • XHR $8.55
  • 52 Week High
  • ATRC $43.11
  • XHR $16.50
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 44.34
  • XHR 67.91
  • Support Level
  • ATRC $30.85
  • XHR $12.39
  • Resistance Level
  • ATRC $33.15
  • XHR $12.89
  • Average True Range (ATR)
  • ATRC 0.98
  • XHR 0.30
  • MACD
  • ATRC -0.10
  • XHR 0.07
  • Stochastic Oscillator
  • ATRC 36.52
  • XHR 93.73

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About XHR Xenia Hotels & Resorts Inc.

Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The room segment contributes to the vast majority of the firm's total revenue. The firm's customer groups include transient business, group business, and contract business.

Share on Social Networks: